Unique Physique vs Enhance MD

Cons

• ✗GLP-1 DRUG MOLECULES NOT NAMED verbatim on the pricing page, weight-loss page, About Our Services page, or FAQ — buyers cannot confirm whether the $195/mo and $325/mo SKUs are semaglutide, tirzepatide, both, or neither without contacting the clinic. This is a critical disclosure gap for a YMYL purchase.
• ✗PHARMACY PARTNER NOT NAMED on any audited page — buyers cannot independently verify the dispensing pharmacy's licensure, 503A vs 503B status, or compounding history.
• ✗503A vs 503B compounding designation NOT disclosed — no compounded-medication FDA disclaimer text surfaced on any audited page, which is below the transparency standard set by peers like Direct GLP, Brightmeds, and AVARA Rx.
• ✗STATE AVAILABILITY NOT enumerated — site only says 'Patient Consultations are Provided by Licensed Clinicians in the Patients State' without listing which states actually have licensed clinicians. Per project data-discipline rule, states_available is left empty.
• ✗REFUND POLICY is explicitly NON-REFUNDABLE per Terms verbatim: 'ANY APPLICABLE FEES AND OTHER CHARGES ARE NOT REFUNDABLE' + 'Medication not picked up after 60 days will be discarded and not eligible for a refund.' No 'not approved → full refund' guarantee that peers like Brightmeds offer.
• ✗LegitScript ID number NOT surfaced — only a static badge image is present. Peers like Embody (ID 46103909) display the verifiable certification number that can be cross-checked against legitscript.com.
• ✗INSURANCE ACCEPTANCE not addressed — cash-pay model implied but not stated; brand-name GLP-1 routing requires $25/mo fee on top of patient's own pharmacy cost.
• ✗LAB WORK requirements not disclosed — no baseline lab requirement, no metabolic-panel cadence, no lab pricing surfaced anywhere on the site.
• ✗BBB profile not surfaced and not actively claimed.
• ✗Confidence is LOW per the project rules because: no named pharmacy partner + no named drug molecule + no enumerated state list + no LegitScript ID + non-refundable terms. Strengths (named LLC + named MD + named Privacy Officer + brick-and-mortar address) prevent demotion, but the gaps are substantial.

Cons

• ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
• ✗Not available in 10 states: Alabama, Arkansas, Georgia, Hawaii, Louisiana, Mississippi, Missouri, South Carolina, Tennessee, West Virginia
• ✗Mandatory lab work adds 5–10 days to onboarding vs. async-only competitors
• ✗No insurance accepted — cash pay, HSA/FSA eligible
• ✗First-month intro pricing resets to full tier rate after 30 days — the $49/$99/$189 numbers are not the ongoing cost